Elixinol Wellness Limited
Other OTCCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Natalie Butler
- Full Time Employees
- 76
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Address
- 680 George Street Sydney NSW Australia 2000
- IPO Date
- Jun 5, 2018
- Website
- elixinolwellness.com
- Similar Companies
- Business
- Elixinol Wellness Limited (ASX: EXL; OTC: ELLXF) is an Australia-based holding company engaged in the hemp industry, innovating, marketing, and selling hemp-derived and other plant-based nutraceutical, skincare, cosmetic, and food products. The company offers a diverse portfolio of brands including Hemp Foods Australia, Mt Elephant, Field Day, Soul Seeds, and The Healthy Chef; core products encompass human nutrition supplements, human wellness items, pet wellness supplements, superfood ingredients, wholefood baking mixes, functional clean foods targeting women's health needs such as gut health, stress relief, sleep, immunity, menopause, ingestible beauty, weight loss, and fitness, as well as hemp-derived and native Australian ingredients. It operates through three segments--Americas, Australia, and Rest of World--with key revenue from Australia via subsidiaries like Elixinol Wellness (Byron Bay) Pty Ltd and The Sustainable Nutrition Group Pty Ltd and its subsidiaries; products are distributed via grocery, wholesale, pharmacy, specialty health, e-commerce, and direct-to-consumer channels in Australia, the United States, United Kingdom, Japan, Brazil, Mexico, and South Africa. Founded in 2017 and headquartered at 100 Albert Road, South Melbourne, Australia, the company in October 2024 entered a binding agreement to acquire 100% of the business assets of The Healthy Chef for $3.1-$5.5 million, funded by a $1.1 million placement, up to $0.5 million share purchase plan, and deferred cash payments, enhancing its portfolio with a high-margin (62%) D2C brand offering immediate revenue growth, cost synergies, and positive EBITDA contribution while securing a U.S. license agreement for expansion; it subsequently completed the share purchase plan raising approximately $420,000 and terminated a U.S. distribution agreement for The Healthy Chef brand in August 2025.
Elixinol Wellness Limited (ELLXF) Shareholder/Analyst Call Prepared Remarks Transcript
Elixinol Wellness Limited (ELLXF) Discusses New National Distribution Agreement and Capital Structure Reset Transcript
Elixinol Wellness Limited (ELLXF) Q4 2025 Earnings Call Transcript
Elixinol Wellness Limited (OTCMKTS:ELLXF) Short Interest Update
Study on the safety of Elixinol Hemp Extract is published in Journal of Toxicology
Elixinol Wellness strikes deal with British Cannabis to continue distribution in the UK
Elixinol Wellness well-funded over next 18 months to take advantage of improving outlook across key markets
Elixinol Wellness delivers best EBITDA and earnings since first half 2019
Elixinol Wellness returns to growth in June quarter as it seeks to expand existing markets and new growth drivers
Elixinol Wellness and CannaCare Health terminate acquisition as changing German market dynamics threaten returns
Elixinol Wellness in trading halt with an announcement related to proposed acquisition pending
Elixinol Wellness and Health House International unite with medicinal cannabis distribution agreement
Elixinol Wellness Makes Key Appointments To Leadership Team
Elixinol Global sees steady improvements in first quarter revenue as UK COVID restrictions ease and US stimulus packages take effect
Elixinol Global's products pass key administrative check by Food Standards Agency and can remain for sale in UK market
Elixinol to Acquire 100% of CannaCare Health
Elixinol Global positions itself as a leading pan-European CBD company by acquiring Germany's CannaCare Health
Elixinol Global in trading halt with potential transaction news pending
Elixinol Global accelerates growth strategy following global re-set of initiatives
Elixinol Global substantial holder Regal Funds Management increases stake